Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Epidemiology Study to Validate the BOMET-QoL-10 in Patients With Bone Metastasis in Germany

NCT02293642 is registered in ClinicalTrials.gov with iOMEDICO AG as lead sponsor.

NCT NCT02293642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02293642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Epidemiology Study to Validate the BOMET-QoL-10 in Patients With Bone Metastasis in Germany
Lead sponsor
iOMEDICO AG
Phase
Observational
Overall status
Completed
Start date
December 31, 2014
Completion date
June 30, 2016
Enrollment
370 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastasis